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longitudinal (–16.1±2.8% vs –21.7±2.2%, p<0.001), 4-chamber LV longitu-
dinal strain (–15±2.8% vs –22.3±1.6%, p<0.001), 2-chamber LV longitudinal
strain (–15.8±3.2% vs –20±1.4%, p<0.001) and overall global LV longitudinal
strain (–14.4±2.5% vs –21.7±1.4%, p<0.0001). Circumferential LV strain was
preserved in patients compared to controls ( –21.7±5.4% vs –23.3±2.7%,
p=0.5). 
Conclusion: In this pilot study, Speckle-tracking echocardiography
revealed impaired LV longitudinal strain in 100% of patients with normal
CMR. Decreased longitudinal LV strain could represent an early sign of myo-
cardial involvement in sarcoidosis patients. Therefore further assessment of
cardiac deformation imaging in the setting of sarcoidosis is needed to improve
the diagnosis of CS (figure above). 
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Background: Antibody-mediated rejection (AMR) is characterized by his-
topathological and immunophenotypic findings such as activated endothelial
cells, intravascular macrophages and evidence of capillary C4d deposition.
This inflammatory reaction could be followed by diffuse fibrosis. Cardiac
magnetic resonance (CMR) with recently T1 mapping is a promising tech-
nique to identify diffuse myocardial fibrosis. The purpose of this study was to
assess T1 mapping in patients with AMR. 
Method: 2 patients with clinical AMR (histopathological and immunophe-
notypic findings, presence of donor-specific allo antibodies and allograft dys-
function) performed a CMR study one week (for the first patient) and 3 weeks
(for the second patient) after the treatment of AMR (plasmapheresis, IV
Immunoglobulins and Rituximab). Images were acquired on a 1.5 Tesla
scanner (Siemens) including T1 mapping using a shortened modified look-
locker inversion-recovery sequence and T2 mapping in a matched mid-ven-
tricular short axis slice using a black- blood single shot fast spin echo pulse
sequence. Segmental and global T1 values were measured before and 15 min-
utes after administration of 0.2 mmol/kg of Gadoteric acid and compared to
our cohort of 17 controls.
Results: Mean non contrast T1 values were significantly higher in heart
transplants patients compared to controls (1100±5ms vs 947±29ms, P <0.001).
Segmental T1 values were significantly higher in the 6 regions of interest
compared to controls (P <0.001 in all segments). Mean post contrast T1 values
were not significantly different in patients and controls. Mean T2 value was
higher in patients compared to controls (73±13 vs 50± 4ms), suggesting the
presence of global edema. 
Conclusion: Heart transplant patients with clinical antibody-mediated
rejection show a significant increased global and segmental non contrast T1
values suggesting the presence of diffuse myocardial fibrosis. Further studies
are required to confirm these data.
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Background: optimal management of patient with small aortic annulus
who require aortic valve replacement (AVR) is debated. The adverse prog-
nostic impact of a prosthesis – patient mismatch (PPM) is well established.
Hemodynamic performance of new generation of rapid deployment aortic bio-
prosthesis with LVOT enlargement by the sub-valvular expandable frame
must be evaluated.
Objectives: to determine the prelimary results (1month FU) in patients
operated on aortic stenosis with Edwards INTUITY bioprosthesis. 
Methods: Inclusion criteria: 1/Severe symptomatic aortic stenosis 2/ Small
aortic annulus 3/ tricuspid aortic valve. Endpoints: 1/ Success of procedure
and in-hospital mortality 2/ post op evolution of mean gradient and indexed
effective orifice area (iEOA) 3/Evolution of LV mass 4/Incidence of peri-
prosthetic regurgitation (PPR) 5/incidence of PPM. 
Results: 38 patients, age = 78.6±6.6, BMI = 25.5± 3.3, Euroscore II= 3.8±
3.6, LVEF = 63.4±10.2%, iAVA = 0.5±0.2cm², mean gradient = 56.7±19.3
mmHg, Stroke volume = 49.9±11.6ml/m², Surgical procedure: full sternotomy
in all, 15 patients with INTUITY 19mm and 23 patients with INTUITY
21mm, CABG in 12 patients (31.6%), Cross clamping time = 45.6±21.1min.
1/ Success of procedure: 100%. In-hospital mortality: 2.6%. 2/ Evolution of
mean gradient and iEOA at 1 month FU = 17.8±12.7 mmHg and 0.7± 0.1 cm²/m²
(INTUITY19mm); 11.9±4.2mmHg and 1± 0.3cm²/m² (INTUITY21mm).
3/ Evolution of LV mass: Significant reduction of LV mass index at
1 month FU (124mg/m2 vs 167mg/m2, p=0,001) 4/Incidence of PPR: No
PPR > grade 1. 5/Incidence of PPM: only six patients (8.3%) with moderate
PPM (ELI <0.85cm²/m²). None with severe PPM. 
Conclusions: These early results suggest potential future applicability of the
Edwards INTUITY in addressing some of the challenges in patients with a small
aortic annulus. Mid-term results in a large population should be evaluated. 
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